Latest News

Central Monitoring is Uncovering Emerging Quality Risks in Clinical Trials
Central Monitoring is Uncovering Emerging Quality Risks in Clinical Trials

February 11th 2025

The long-held practice is effective in pinpointing the emergence of known and unknown risks to clinical development, study shows.

Credit: Matthieu | stock.adobe.com
EV-302 Trial Confirms Sustained Survival Benefits with Padcev-Keytruda Combo in Locally Advanced or Metastatic Urothelial Cancer

February 11th 2025

Replacing Anecdotal With Empirical Evidence On Impact of DCTs
Replacing Anecdotal With Empirical Evidence On Impact of DCTs

February 11th 2025

In Focus: The Top Needs in a Clinical Trials Software Package
In Focus: The Top Needs in a Clinical Trials Software Package

February 11th 2025

SCOPE Summit 2025: The Importance of Language in Patient Engagement
SCOPE Summit 2025: The Importance of Language in Patient Engagement

February 11th 2025

Applied Clinical Trials December 2024

Check out the latest features and columns!

Check out the latest features and columns!

Conference Coverage

View All
SCOPE Summit 2025: The Importance of Language in Patient Engagement
SCOPE Summit 2025: The Importance of Language in Patient Engagement

February 11th 2025

SCOPE Summit 2025: Richard Young Discusses Key Takeaways and the Future of RBQM
SCOPE Summit 2025: Richard Young Discusses Key Takeaways and the Future of RBQM

February 10th 2025

SCOPE Summit 2025: Peter Ronco Offers Tips to Small Biopharma Companies on Properly Scaling Clinical Programs
SCOPE Summit 2025: Peter Ronco Offers Tips to Small Biopharma Companies on Properly Scaling Clinical Programs

February 7th 2025

SCOPE Summit 2025: Richard Young on CluePoints' Approach to Risk Detection in Clinical Trials
SCOPE Summit 2025: Richard Young on CluePoints' Approach to Risk Detection in Clinical Trials

February 7th 2025

Latest Videos
Podcasts
© Alex from the Rock - © Alex from the Rock - stock.adobe.com

All News

© 2025 MJH Life Sciences

All rights reserved.